Transsphenoidal Pituitary Surgery
Airway: Access: Pain: Position: Time: Blood loss: Special:
Intro and technique
Considerations
- A
- Oral RAE/Reinforced tube
- B
- No HFNP or CPAP post-operatively
Difficult in OSA patients.- Extubate light
- Consider remifentanil TIVA
- No HFNP or CPAP post-operatively
- C
- Arterial line
- HTN on nasal preparation
- D
- MRI
Sizing.
- MRI
- E
- Tumour function
Tumour can be functional or non-functional.- Functional
Present with symptoms from hypersecretion. - Non-functional
Present with compression symptoms.- Bitemporal hemianopia
Optic chiasm compression.
- Bitemporal hemianopia
- Functional
- Hormonal screen
- Tumour function
- F
- Diabetes Insipidus
10-60% of cases occur almost immediately.
- Diabetes Insipidus
Preoperative
Assess:
Mass effect
Metabolic effects
Standard ANZCA monitoring
Arterial line
Large IV
Oral RAE or reinforced tube
IDC
Position:
- Semi-recumbent
Induction
Intraoperative
Surgical Stages
Emergence
Postoperative
Surgical complications:
- CSF leak
- Pack sella with fat
- May need lumbar drain
- Hydrocephalus
- Bleeding
- Visual problems
- Direct damage
3.3%.
- Direct damage
Hormonal complications:
- Usually enough residual pituitary tissue is present to provide normal pituitary function
- Posterior pituitary dysfunction is more common due to oedema
- Hormonal screen performed 2-3 days
- DI
- ~15%
Bulk of cases develop immediately. - Usually transient
- ~15%
- SIADH
- Develops slowly